![George Pentheroudakis(@GPentheroudakis) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1308542323249352710/VHz1tQBP_200x200.jpg)
George Pentheroudakis
@GPentheroudakis
Chief Medical Officer, ESMO
ID:1130178669165580289
19-05-2019 18:29:27
281 Tweets
329 Followers
70 Following
![George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1308542323249352710/VHz1tQBP_200x200.jpg)
ESMO Adaptation of Lines of Systemic Therapy ( EnLiST): Evandro de Azambuja, MD, PhD Diogo Martins Branco ESMO - Eur. Oncology
![George Pentheroudakis (@GPentheroudakis) on Twitter photo 2024-04-20 20:08:14 ESMO Adaptation of Lines of Systemic Therapy ( EnLiST): @E_de_Azambuja @DMBranco @myESMO ESMO Adaptation of Lines of Systemic Therapy ( EnLiST): @E_de_Azambuja @DMBranco @myESMO](https://pbs.twimg.com/media/GLokp18WEAAeAgr.jpg)
![Myriam Chalabi(@MyriamChalabi) 's Twitter Profile Photo Myriam Chalabi(@MyriamChalabi) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1196548679215259648/uMv4JCfx_200x200.jpg)
What happens in Zurich….goes to #ESMO25 ! Fantastic meeting and discussions for the educations, together with my scientific co-chair Toni Choueiri, MD ! New tracks, new concepts and the best experts! Mark your agendas for #Berlin ! ESMO - Eur. Oncology
![Myriam Chalabi (@MyriamChalabi) on Twitter photo 2024-04-19 17:06:51 What happens in Zurich….goes to #ESMO25 ! Fantastic meeting and discussions for the educations, together with my scientific co-chair @DrChoueiri ! New tracks, new concepts and the best experts! Mark your agendas for #Berlin! @myESMO What happens in Zurich….goes to #ESMO25 ! Fantastic meeting and discussions for the educations, together with my scientific co-chair @DrChoueiri ! New tracks, new concepts and the best experts! Mark your agendas for #Berlin! @myESMO](https://pbs.twimg.com/media/GLixjRpXkAA372S.jpg)
![George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1308542323249352710/VHz1tQBP_200x200.jpg)
Brainstorming on EnLiST, the ESMO - Eur. Oncology ESMO Adaptation of Lines of Systemic Therapy, with Chris Twelves, Kamal Saini, Miriam Koopman, Suzette Delaloze, the ESMO Real World Data Digital Working Group and individual experts from EMA FDA Industry EORTC CRO Patient Advocates
![George Pentheroudakis (@GPentheroudakis) on Twitter photo 2024-04-20 16:53:48 Brainstorming on EnLiST, the @myESMO ESMO Adaptation of Lines of Systemic Therapy, with Chris Twelves, Kamal Saini, Miriam Koopman, Suzette Delaloze, the ESMO Real World Data Digital Working Group and individual experts from EMA FDA Industry EORTC CRO Patient Advocates Brainstorming on EnLiST, the @myESMO ESMO Adaptation of Lines of Systemic Therapy, with Chris Twelves, Kamal Saini, Miriam Koopman, Suzette Delaloze, the ESMO Real World Data Digital Working Group and individual experts from EMA FDA Industry EORTC CRO Patient Advocates](https://pbs.twimg.com/media/GLn4J0mWsAQBvDR.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
➡️Secure your place now to stay up-to-date with the ongoing European efforts in digital health interoperability for an optimal clinical data exchange. Register now for this #DigitalOncology webinar: 🔗ow.ly/IzCW50Rj5tX
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-04-19 05:00:33 ➡️Secure your place now to stay up-to-date with the ongoing European efforts in digital health interoperability for an optimal clinical data exchange. Register now for this #DigitalOncology webinar: 🔗ow.ly/IzCW50Rj5tX ➡️Secure your place now to stay up-to-date with the ongoing European efforts in digital health interoperability for an optimal clinical data exchange. Register now for this #DigitalOncology webinar: 🔗ow.ly/IzCW50Rj5tX](https://pbs.twimg.com/media/GLgLUYsWwAA0fLG.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community.
Access with your ESMO account: 🔗ow.ly/QbL750Rj8oz
Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-04-19 14:55:15 👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community. Access with your ESMO account: 🔗ow.ly/QbL750Rj8oz @clacardone @VivekSubbiah @SewantiLimaye @BenWestphalen @GPentheroudakis 👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community. Access with your ESMO account: 🔗ow.ly/QbL750Rj8oz @clacardone @VivekSubbiah @SewantiLimaye @BenWestphalen @GPentheroudakis](https://pbs.twimg.com/media/GLiTb0yWwAEDxeI.jpg)
![Diogo Martins Branco(@DMBranco) 's Twitter Profile Photo Diogo Martins Branco(@DMBranco) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1700115811053027328/3twxTquC_200x200.jpg)
📢The ESMO - Eur. Oncology #PrecisionMedicine Working Group will 🔜 launch a new tool for screening #TumourAgnostic potential & a therapeutic effect #taxonomy as part of a proposed drug development framework ‼️
👉Stay tuned
![Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo Paolo Tarantino(@PTarantinoMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1454840948349939718/N7-QBrt1_200x200.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
📣The last webinar in the #PrecisionOncology series presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Register now:🔗ow.ly/8xBH50R8aFI
Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-04-05 11:01:25 📣The last webinar in the #PrecisionOncology series presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Register now:🔗ow.ly/8xBH50R8aFI @clacardone @VivekSubbiah @SewantiLimaye @BenWestphalen @GPentheroudakis 📣The last webinar in the #PrecisionOncology series presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Register now:🔗ow.ly/8xBH50R8aFI @clacardone @VivekSubbiah @SewantiLimaye @BenWestphalen @GPentheroudakis](https://pbs.twimg.com/media/GKZXqEHXgAAOZU-.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
📅 A unique opportunity to have your questions answered by world-renowned experts in #BreastCancer
Register now to enjoy this ESMO member benefit:
🔗ow.ly/ehpN50R4ZfI
#ESMODeepDive
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-04-08 07:00:27 📅 A unique opportunity to have your questions answered by world-renowned experts in #BreastCancer Register now to enjoy this ESMO member benefit: 🔗ow.ly/ehpN50R4ZfI #ESMODeepDive 📅 A unique opportunity to have your questions answered by world-renowned experts in #BreastCancer Register now to enjoy this ESMO member benefit: 🔗ow.ly/ehpN50R4ZfI #ESMODeepDive](https://pbs.twimg.com/media/GKn9Rm6XQAAJKwK.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
📢New edition of ' #Lymphomas : Essentials for Clinicians' now available. This #ESMOBook is mainly addressed towards junior doctors but is also suitable for general oncologists or haematologists who want to stay updated. ow.ly/FGCt50R1lqk
Ivana Božović Raffaele Califano Tania Fleitas Kanonnikoff
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-03-26 11:26:19 📢New edition of '#Lymphomas: Essentials for Clinicians' now available. This #ESMOBook is mainly addressed towards junior doctors but is also suitable for general oncologists or haematologists who want to stay updated. ow.ly/FGCt50R1lqk @bozovicspa @caliraf @tfleitask 📢New edition of '#Lymphomas: Essentials for Clinicians' now available. This #ESMOBook is mainly addressed towards junior doctors but is also suitable for general oncologists or haematologists who want to stay updated. ow.ly/FGCt50R1lqk @bozovicspa @caliraf @tfleitask](https://pbs.twimg.com/media/GJl9Yi4XMAAZpWW.jpg)
![George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1308542323249352710/VHz1tQBP_200x200.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
Just out 📢 The new ESMO Living Guideline on Non-Oncogene-Addicted Metastatic Non-Small-Cell #LungCancer . Updated treatment algorithms & recommendations, directly linked to ESMO-MCBS scores & references, easily accessible on desktop & mobile devices. ow.ly/fTm250QWY2i
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-03-19 17:50:11 Just out 📢 The new ESMO Living Guideline on Non-Oncogene-Addicted Metastatic Non-Small-Cell #LungCancer. Updated treatment algorithms & recommendations, directly linked to ESMO-MCBS scores & references, easily accessible on desktop & mobile devices. ow.ly/fTm250QWY2i Just out 📢 The new ESMO Living Guideline on Non-Oncogene-Addicted Metastatic Non-Small-Cell #LungCancer. Updated treatment algorithms & recommendations, directly linked to ESMO-MCBS scores & references, easily accessible on desktop & mobile devices. ow.ly/fTm250QWY2i](https://pbs.twimg.com/media/GJDR4-VWwAAFeyv.jpg)
![George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1308542323249352710/VHz1tQBP_200x200.jpg)
![George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1308542323249352710/VHz1tQBP_200x200.jpg)
![George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo George Pentheroudakis(@GPentheroudakis) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1308542323249352710/VHz1tQBP_200x200.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
#ESMOGI24 : the Scientific Co-Chairs – Eric Van Cutsem, Ducreux Michel, Teresa Macarulla - look forward to receiving yr contributions & welcoming you to Munich for what promises to be an enlightening and impactful congress. 📣 Submit yr abstract by 9 Apr
🔗ow.ly/p71i50QJmGe
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-03-04 08:00:18 #ESMOGI24: the Scientific Co-Chairs – Eric Van Cutsem, @DucreuxMichel, @MacarullaTeresa - look forward to receiving yr contributions & welcoming you to Munich for what promises to be an enlightening and impactful congress. 📣 Submit yr abstract by 9 Apr 🔗ow.ly/p71i50QJmGe #ESMOGI24: the Scientific Co-Chairs – Eric Van Cutsem, @DucreuxMichel, @MacarullaTeresa - look forward to receiving yr contributions & welcoming you to Munich for what promises to be an enlightening and impactful congress. 📣 Submit yr abstract by 9 Apr 🔗ow.ly/p71i50QJmGe](https://pbs.twimg.com/media/GHz7U_DWQAAH19L.jpg)
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
Scientific Co-Chairs, Eric Van Cutsem, Ducreux Michel & Teresa Macarulla, as well as members of the Scientific Committee & experts in the field, give their reasons why you should attend #ESMOGI24 , on 26-29 June, in Munich. Register by 10 April and save.
🔗ow.ly/K5hS50QBGO5
![Diogo Martins Branco(@DMBranco) 's Twitter Profile Photo Diogo Martins Branco(@DMBranco) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1700115811053027328/3twxTquC_200x200.jpg)
![Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo Annals of Oncology(@Annals_Oncology) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1212658619667365889/FXP-OFGP_200x200.png)
The abstract of the 15 February 2024 #ESMOVirtualPlenary is available in Annals of Oncology
👇
Event-free survival and overall survival of neoadjuvant tislelizumab (TIS) plus chemotherapy with adjuvant TIS in resectable NSCLC annalsofoncology.org/article/S0923-…
#LCSM ESMO - Eur. Oncology
![ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo ESMO - Eur. Oncology(@myESMO) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/459333051764318208/N9TasZ4x_200x200.jpeg)
#ESMODailyReporter : Perioperative tislelizumab improves survival in resectable #NSCLC – a new standard of care? Encouraging EFS & OS results presented at today's #ESMOVirtualPlenary for the use of the immune checkpoint inhibitor before & after surgery.
ow.ly/iSRe50QC79s?
![ESMO - Eur. Oncology (@myESMO) on Twitter photo 2024-02-15 18:35:13 #ESMODailyReporter: Perioperative tislelizumab improves survival in resectable #NSCLC – a new standard of care? Encouraging EFS & OS results presented at today's #ESMOVirtualPlenary for the use of the immune checkpoint inhibitor before & after surgery. ow.ly/iSRe50QC79s? #ESMODailyReporter: Perioperative tislelizumab improves survival in resectable #NSCLC – a new standard of care? Encouraging EFS & OS results presented at today's #ESMOVirtualPlenary for the use of the immune checkpoint inhibitor before & after surgery. ow.ly/iSRe50QC79s?](https://pbs.twimg.com/media/GGZgB8EXMAAIf5g.jpg)